AMERIPRISE FINANCIAL INC
AMPNYSE🏆 #327 by market capEarnings Oct 29 · PostUS Equity
$497.09▲ $0.94 (+0.19%)
LiveTrack AMP
Get earnings, price moves & breaking news on Telegram
24h▲ 0.2%
7d▼ 2.9%
14d▼ 11.1%
30d▼ 11.1%
ytd▲ 1.3%
1y▼ 0.4%
🏦Market Cap
$44.69B
Mid Cap
📈Revenue Growth (YoY)
+5.2%
Slowing
📊Gross Margin
50.2%
Healthy
💵FCF Margin
40.7%
Strong
⚖️P/S Ratio
2.2x
Cheap
Otter Score
68
Fair
AMERIPRISE FINANCIAL INC
AMPAnalyst Ratings
Price
$497.09
Total
22
Raised
0
Lowered
4
Avg PT
$556.67
H / L
$645 / $489
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Argus Research | Reiterated | Buy | 2026-07-31 | $460.00 | −7.50% |
RBC Capital | Reiterated | Outperform | 2026-07-24 | $560.00 | +12.70% |
Keefe, Bruyette & Woods | Reiterated | Market Perform | 2026-07-24 | — | — |
Evercore ISI Group | Reiterated | In Line | 2026-07-13 | — | — |
Piper Sandler | Reiterated | Neutral | 2026-07-13 | $518.00 | +4.20% |
Jefferies | Reiterated | Buy | 2026-07-10 | $645.00 | +29.80% |
Morgan Stanley | Reiterated | Underweight | 2026-07-10 | $489.00 | −1.60% |
BMO Capital | Reiterated | Market Perform | 2026-05-20 | $490.00 | −1.40% |
William Blair | Downgraded | Outperform → Market Perform | 2025-07-25 | — | — |
Raymond James | Reiterated | Strong Buy | 2025-07-25 | $638.00 | +28.30% |
UBS | Downgraded | Buy → Neutral | 2025-01-06 | $495.00 | −0.40% |
Goldman Sachs | Reiterated | Buy | 2024-03-27 | $476.00 | −4.20% |
Credit Suisse | Reiterated | Outperform | 2023-02-01 | — | — |
B of A Securities | Reiterated | Buy | 2022-09-07 | — | — |
Citigroup | Reiterated | Buy | 2021-06-21 | — | — |
Barclays | Reiterated | Overweight | 2021-04-12 | — | — |
CFRA | Reiterated | Buy | 2020-05-13 | — | — |
SunTrust Robinson Humphrey | Reiterated | Hold | 2017-10-26 | — | — |
Deutsche Bank | Downgraded | Buy → Hold | 2016-10-14 | — | — |
Wells Fargo | Downgraded | Outperform → Market Perform | 2016-01-13 | — | — |
Keefe Bruyette & Woods | Reiterated | Outperform | 2015-10-12 | — | — |
Sterne Agee | Reiterated | Neutral | 2014-10-13 | — | — |
Institution
Argus Research
Reiterated · Buy · 2026-07-31
$460.00
−7.50%
RBC Capital
Reiterated · Outperform · 2026-07-24
$560.00
+12.70%
Keefe, Bruyette & Woods
Reiterated · Market Perform · 2026-07-24
—
—
Evercore ISI Group
Reiterated · In Line · 2026-07-13
—
—
Piper Sandler
Reiterated · Neutral · 2026-07-13
$518.00
+4.20%
Jefferies
Reiterated · Buy · 2026-07-10
$645.00
+29.80%
Morgan Stanley
Reiterated · Underweight · 2026-07-10
$489.00
−1.60%
BMO Capital
Reiterated · Market Perform · 2026-05-20
$490.00
−1.40%
William Blair
Downgraded · Outperform → Market Perform · 2025-07-25
—
—
Raymond James
Reiterated · Strong Buy · 2025-07-25
$638.00
+28.30%
UBS
Downgraded · Buy → Neutral · 2025-01-06
$495.00
−0.40%
Goldman Sachs
Reiterated · Buy · 2024-03-27
$476.00
−4.20%
Credit Suisse
Reiterated · Outperform · 2023-02-01
—
—
B of A Securities
Reiterated · Buy · 2022-09-07
—
—
Citigroup
Reiterated · Buy · 2021-06-21
—
—
Barclays
Reiterated · Overweight · 2021-04-12
—
—
CFRA
Reiterated · Buy · 2020-05-13
—
—
SunTrust Robinson Humphrey
Reiterated · Hold · 2017-10-26
—
—
Deutsche Bank
Downgraded · Buy → Hold · 2016-10-14
—
—
Wells Fargo
Downgraded · Outperform → Market Perform · 2016-01-13
—
—
Keefe Bruyette & Woods
Reiterated · Outperform · 2015-10-12
—
—
Sterne Agee
Reiterated · Neutral · 2014-10-13
—
—
One row per institution · price target from the firm's latest published target